Wishing Mr. Rishi Kapoor greater responsibilities and exciting challenges in this impressive new chapter!
Biodeal Pharmaceuticals Limited has announced the appointment of Mr Rishi Kapoor as its new Chief Financial and Business Officer. Bringing over two decades of extensive financial leadership experience, Rishi will play a key role in strengthening Biodeal’s financial foundation and guiding its upcoming IPO journey.
Rishi Kapoor’s career spans more than 20 years across industries including pharmaceuticals, healthcare, EdTech, IT, and retail. He has held prominent leadership roles at Girnar Group, Corbus LLC, Amrapali Group, Future Group, and Max Healthcare. His expertise covers strategic finance, fundraising, investor relations, mergers and acquisitions, and IPO management.
A Chartered Accountant and Master in Finance, Rishi is also a Lifetime Certified Independent Director from the Indian Institute of Corporate Affairs and Six Sigma Yellow Belt certified. Throughout his career, he has successfully driven major equity and debt fundraises, managed large-scale acquisitions and integrations, and led transformative finance projects across global markets.
Recognised as one of India’s Top 10 Most Dynamic Revenue and Growth Leaders 2025 by a reputed business publication, Rishi has been acknowledged for his consistent contributions to financial innovation and organisational growth. His strategic insights and leadership have helped businesses strengthen governance, enhance financial performance, and build investor confidence.
At Biodeal Pharmaceuticals, Rishi will lead the company’s financial strategy, investor engagement, and automation of financial systems. His focus will be on driving efficiency, optimising capital structure, and supporting Biodeal’s long-term growth objectives. He will also serve as a trusted advisor to the executive leadership team, offering strategic consultation on financial planning, business policy, and sustainable growth initiatives.
With his proven track record and deep industry knowledge, Rishi Kapoor’s appointment marks a significant step in Biodeal’s journey towards innovation, financial excellence, and market leadership.
Also read: Viksit Workforce for a Viksit Bharat
Do Follow: The Mainstream formerly known as CIO News LinkedIn Account | The Mainstream formerly known as CIO News Facebook | The Mainstream formerly known as CIO News Youtube | The Mainstream formerly known as CIO News Twitter |The Mainstream formerly known as CIO News Whatsapp Channel | The Mainstream formerly known as CIO News Instagram
About us:
The Mainstream formerly known as CIO News is a premier platform dedicated to delivering latest news, updates, and insights from the tech industry. With its strong foundation of intellectual property and thought leadership, the platform is well-positioned to stay ahead of the curve and lead conversations about how technology shapes our world. From its early days as CIO News to its rebranding as The Mainstream on November 28, 2024, it has been expanding its global reach, targeting key markets in the Middle East & Africa, ASEAN, the USA, and the UK. The Mainstream is a vision to put technology at the center of every conversation, inspiring professionals and organizations to embrace the future of tech.
